Catalyst Brief

← Calendar

Readoutin 134d

Boehringer Ingelheim — Nerandomilast

Phase 3 primary completion: A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast.

Date
Apr 2027
Type
Readout
Indication
Idiopathic Pulmonary Fibrosis

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Boehringer Ingelheim

  1. Apr2027
  2. Dec2026